Navigation Links
XE-2100

ProductsXE-2100
Company Sysmex America, Inc.
Item XE-2100
Features Network capability allows for easy integration into a computer network system, provides excellent separation or normal as well as abnormal cell populations by patented new technology of fluorescent reagents, exhibits high performances with a throughput of up to 150 samples/hour; various types of discrete modes and real-time random access testing increase cost effectiveness higher productivity is acquired by connecting two units with optional TCM software, more efficient reagent management or more enhanced analysis can be realized by upgrade-software products (XE pro series).
Description The XE-2100 automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information.
Info Sysmex America, Inc.Call Sysmex America, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-394-3469

Customer Service: 1-800-379-7639

Related medicine products :

1. XE-2100L
2. Sysmex XE-2100™ Automated Hematology Analyzer
TAG:
Breaking Medicine News(10 mins):Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 3Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2
Other Medicine News:Health News:Grocery Manufacturers Association Statement Regarding President Obama's Nomination of FDA Commissioner 2Health News:Appointment of Margaret Hamburg to Lead FDA Lauded by Gov. Lowell Weicker, President of the Board of Trust for America's Health 2Health News:Honolulu Opthalmologist Alan R. Faulkner, MD Discusses Advantages of Implantable Contact Lenses (ICL) over LASIK Laser Vision Correction 2Health News:Honolulu Opthalmologist Alan R. Faulkner, MD Discusses Advantages of Implantable Contact Lenses (ICL) over LASIK Laser Vision Correction 3Health News:Advanced Data System's MedicsDocAssistant™ EHR Receives 08 CCHIT Certification 2Health News:Advanced Data System's MedicsDocAssistant™ EHR Receives 08 CCHIT Certification 3Health News:ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board 2Health News:Northwestern Memorial's Heart Transplant Program No. 1 in Illinois and Among Highest-Rated Nationally 2Health News:Northwestern Memorial's Heart Transplant Program No. 1 in Illinois and Among Highest-Rated Nationally 3
Breaking Medicine Technology:$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Roche Diagnostics Opens State-of-the-Art Training Center in California 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform 3B All Demographics Report Per 49043 1New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform 3B All Demographics Report Per 49043 2New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform 3B All Demographics Report Per 49043 3New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform 3B All Demographics Report Per 49043 4A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center 49039 1A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center 49039 2A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center 49039 3VIDEO 3A Perot Systems Launches Xcelys 28TM 29 for Revenue Cycle Management 49036 1VIDEO 3A Perot Systems Launches Xcelys 28TM 29 for Revenue Cycle Management 49036 2VIDEO 3A Perot Systems Launches Xcelys 28TM 29 for Revenue Cycle Management 49036 3